PomDoctor Ltd
POM0.243USD
+0.000+0.04%
Close 02/02, 16:00（ET）Quotes delayed by 15 min
4.80MMarket Cap
LossP/E TTM
More Details of PomDoctor Ltd Company
PomDoctor Ltd is a company that mainly operates an online medical services platform for chronic diseases. The Company's business model focuses on chronic disease management and pharmaceutical services, forming a one-stop medical service platform that connects patients with doctors and pharmaceutical products. It helps patients to conveniently connect with doctors and obtain one-stop medical services.
PomDoctor Ltd Info
Ticker SymbolPOM
Company namePomDoctor Ltd
IPO dateOct 08, 2025
CEOShi (Zhenyang)
Number of employees156
Security typeDepository Receipt
Fiscal year-endOct 08
AddressYongxu Industrial Park
CityGUANGZHOU
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryChina
Postal code510000
Phone862062312277
Websitehttps://www.7lk.com/
Ticker SymbolPOM
IPO dateOct 08, 2025
CEOShi (Zhenyang)
Company Executives of PomDoctor Ltd
Name
Name/Position
Position
Shareholding
Change
Mr. Zhenyang Shi
Mr. Zhenyang Shi
Co-Founder, Chairman of the Board, Chief Executive Officer
Co-Founder, Chairman of the Board, Chief Executive Officer
--
--
Ms. Li Xu
Ms. Li Xu
Co-Founder, Chief Financial Officer
Co-Founder, Chief Financial Officer
--
--
Mr. Guoji Luo
Mr. Guoji Luo
Vice President, Director Appointee
Vice President, Director Appointee
--
--
Mr. Dexiang Wei
Mr. Dexiang Wei
Vice President
Vice President
--
--
Ms. Yuanyuan Jing
Ms. Yuanyuan Jing
Independent Director Appointee
Independent Director Appointee
--
--
Mr. Wenqing Bao
Mr. Wenqing Bao
Independent Director Appointee
Independent Director Appointee
--
--
Mr. Daxue Li
Mr. Daxue Li
Independent Director Appointee
Independent Director Appointee
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Zhenyang Shi
Mr. Zhenyang Shi
Co-Founder, Chairman of the Board, Chief Executive Officer
Co-Founder, Chairman of the Board, Chief Executive Officer
--
--
Ms. Li Xu
Ms. Li Xu
Co-Founder, Chief Financial Officer
Co-Founder, Chief Financial Officer
--
--
Mr. Guoji Luo
Mr. Guoji Luo
Vice President, Director Appointee
Vice President, Director Appointee
--
--
Mr. Dexiang Wei
Mr. Dexiang Wei
Vice President
Vice President
--
--
Ms. Yuanyuan Jing
Ms. Yuanyuan Jing
Independent Director Appointee
Independent Director Appointee
--
--
Mr. Wenqing Bao
Mr. Wenqing Bao
Independent Director Appointee
Independent Director Appointee
--
--
Revenue Breakdown
Currency: USDUpdated: Tue, Jan 6
Currency: USDUpdated: Tue, Jan 6
FY2024
FY2023
By BusinessUSD
Name
Revenue
Proportion
Prescription drugs
259.11M
75.64%
Over the counter(OTC)medicines
71.65M
20.92%
Traditional chinese medicine(TCM)
6.04M
1.76%
Others
4.38M
1.28%
Online consultaion
1.19M
0.35%
Mediccal apparatus and instruments(MAAI)
188.05K
0.05%
Relevant data have not been disclosed by the company yet.
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Prescription drugs
259.11M
75.64%
Over the counter(OTC)medicines
71.65M
20.92%
Traditional chinese medicine(TCM)
6.04M
1.76%
Others
4.38M
1.28%
Online consultaion
1.19M
0.35%
Mediccal apparatus and instruments(MAAI)
188.05K
0.05%
Shareholding Stats
Updated: Sun, Feb 1
Updated: Sun, Feb 1
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
UBS Financial Services, Inc.
0.21%
Other
99.79%
Shareholders
Shareholders
Proportion
UBS Financial Services, Inc.
0.21%
Other
99.79%
Shareholder Types
Shareholders
Proportion
Investment Advisor
0.21%
Other
99.79%
Institutional Shareholding
Updated: Sun, Feb 1
Updated: Sun, Feb 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
1
221.26K
0.21%
+221.26K
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
No Data
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Splits
Date
Ex-dividend Date
Type
Ratio
No Data
Date
Ex-dividend Date
Type
Ratio
No Data
